Epicutaneous Immunotherapy Skin Heating for Rapid Antigen Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current epicutaneous allergen-specific immunotherapy methods are limited by slow response times, inefficiency, and inapplicability to all age groups, particularly lacking a rapid and reliable diagnostic method for diseases like tuberculosis.
Innovation Solution
A skin heating device and method that applies controlled heat to the skin surface, administers an antigen, and evaluates the immunological response, enabling rapid detection of diseases and immune responses through innate immune memory.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If transdermal patches are worn for several days to produce desired effects, then the allergen-specific immunotherapy is effective, but the treatment time is prolonged and the response speed is slow
Solution Approach 1:
The skin surface is pre-heated to a controlled temperature (e.g., 40-50°C) before antigen application to enhance permeability and prepare the skin for faster antigen uptake. This preliminary thermal preparation enables the antigen to be absorbed more rapidly, reducing the required treatment duration from several days to hours or minutes while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent changes the temperature parameter of the skin surface to enhance antigen penetration. By controlling the skin temperature within a specific range during antigen application, the absorption rate is significantly increased, allowing for rapid immunotherapy response without compromising the reliability of the treatment effect.
2Reliability
If epicutaneous immunotherapy disrupts the epidermis to improve antigen uptake, then the therapy becomes more effective, but the safety and patient comfort are compromised
Solution Approach 1:
Instead of disrupting the epidermis, the patent changes the temperature parameter of the skin surface to a controlled, non-damaging range (e.g., 40-50°C). This thermal parameter change enhances antigen permeability through increased skin flexibility and pore opening without causing tissue damage, thereby maintaining both safety and therapeutic efficacy.
Solution Approach 2:
The controlled heat acts as an intermediary that facilitates antigen penetration through the intact epidermis. The thermal energy temporarily increases skin permeability without breaking the skin barrier, allowing the antigen to reach the Langerhans cells effectively while preserving skin integrity and avoiding the harmful effects of epidermal disruption.
3Ease of operation
If transdermal patches are used for epicutaneous immunotherapy, then the treatment can be administered, but the method is only effective in young patients under 13 years old
Solution Approach 1:
The patent adjusts the temperature parameter to be controlled and adjustable, allowing optimization for different skin types and age groups. By precisely controlling the thermal parameters within a safe range, the method becomes adaptable to patients of all ages, including adults whose skin may be less permeable than that of children, thereby expanding the applicability beyond the 13-year age limit.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides rapid, reliable, and age-independent diagnosis and treatment of diseases, including tuberculosis, with results in minutes to hours, suitable for point-of-care diagnostics and immunotherapy.
Implementation Method 1
applying a controlled amount of heat to the skin surface area
Implementation Method 2
a source of heat and at least one contact surface coupled to the source of heat and being adapted to contact a skin surface area
Data Source
AI summary
A method of immunological evaluation includes cleaning a patient skin surface area. A controlled amount of heat is then applied to the skin surface area. The controlled amount of heat is removed after the skin surface area reaches a predetermined temperature. An amount of antigen is deposited onto the skin surface area and incubated for a predetermined amount of time on the skin surface area. The antigen is removed from the skin surface area and an immunological response at the skin surface area is evaluated, such as but not limited to disease detection or antibody response. According to at least one other version, the method can further be utilized for purposes of vaccine immunization. Apparatuses for administering heat and memorializing the immunological evaluation are also disclosed.